When I was diagnosed with idiopathic pulmonary fibrosis (IPF), I didn’t comprehend what the disease could do to a person’s body. Normally, losing weight would be an ideal situation. For me, it was essential because I needed to lose 80 pounds to be under the required body mass index…
Here’s How My Body Changed on My Journey with IPF
Linking the small antifibrotic protein interleukin-10 (IL-10) to a hydrogel vehicle allows safe delivery to the lungs of animal models of pulmonary fibrosis. This formulation could be a potential therapy for people with idiopathic pulmonary fibrosis (IPF). The study, “Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung…
Editor’s note: Brad Dell, the head of columns for Bionews Services, wrote this column. When I walked into Kim Fredrickson’s room in the intensive care unit (ICU), my emotions ripped me this way and that — grief, relief, anxiety, joy — all fluctuating and overwhelming. Once Kim smiled at…
Ofev (nintedanib) may exert its therapeutic benefits by halting the activity of genes that promote proliferation of fibroblasts in idiopathic pulmonary fibrosis (IPF), a next-generation sequencing study suggests. The study “Gene Expression Changes Associated with Nintedanib Treatment in Idiopathic Pulmonary Fibrosis Fibroblasts: A Next-Generation Sequencing and Bioinformatics…
With each new advance in medicine comes ethical dilemmas, from fertility treatments and newborn screening, to vaccinations, gene therapies and euthanasia. But rare diseases and the expensive therapies needed to treat them — particularly in an age of scarce economic resources — almost always entail “tragic choices,” warned Avraham Steinberg,…
The medical advisory board of the Pulmonary Fibrosis Foundation (PFF) strongly cautions patients with pulmonary fibrosis (PF) not to receive stem cell or cell-based treatments outside an approved clinical trial. The PFF statement is an update to a first version published in 2015. “We understand that patients are…
Frailty and geriatric conditions, such as incontinence, dizziness, vision impairment, hearing impairment, and falls, are common among older patients with idiopathic pulmonary fibrosis (IPF), a pilot study finds. Recognition of such commonly associated age-related complications may help identify IPF patients at risk of a poorer outcome, researchers suggest. The study,…
While it sounds cliché to talk about the importance of focusing on quality moments in our lives rather than quantity, doing so is how I choose to live and cope with my life-threatening lung disease. I have learned so much since being diagnosed with idiopathic pulmonary fibrosis…
Rare diseases affect about 30 million Americans — roughly the same number as those with type 2 diabetes. Yet only 5 percent of the estimated 7,000 rare diseases known to science have cures or treatments approved by the U.S. Food and Drug Administration (FDA). Raising awareness of those illnesses and highlighting…
Measuring the loss of skeletal muscle mass in the thoracic area using computed tomography (CT) scans may predict clinical outcomes such as survival in patients with idiopathic pulmonary fibrosis (IPF), according to a study. The study, “Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis…
